Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
Key Highlights
- ➤Cronos (CRON) completed CanAdelaar acquisition for €57.5 million base price.
- ➤Cash earnout equals 0.5x Normalized EBITDA in each of 2026 and 2027.
- ➤CanAdelaar holds leading market share in Europe’s largest adult-use cannabis market.
- ➤CanAdelaar annualized 1H 2026 net revenue reached €41.6 million.
- ➤CanAdelaar annualized 1H 2026 Adjusted EBITDA totaled €20.1 million.
Expert Statements
Mike Gorenstein, Chairman, President and CEO of Cronos
“This is a milestone for Cronos”
Mike Gorenstein, Chairman, President and CEO of Cronos
“With the completion of this transaction, we have established a meaningful and scalable platform in Europe’s largest adult-use cannabis market.”
Mike Gorenstein, Chairman, President and CEO of Cronos
“CanAdelaar is the clear market leader in the Wietexperiment, with a proven operational track record, strong management team, and leading market share.”
Mike Gorenstein, Chairman, President and CEO of Cronos
“We are excited to welcome the CanAdelaar team to Cronos and accelerate execution of our borderless product strategy in the Netherlands.”
Mike Gorenstein, Chairman, President and CEO of Cronos
“With our preparations well underway, we look forward to bringing our innovative, borderless products to Dutch adult-use consumers.”
Christopher Martens, Former CEO of CanAdelaar and newly appointed General Manager, Cronos Netherlands
“Joining Cronos is a natural next step for CanAdelaar”
Christopher Martens, Former CEO of CanAdelaar and newly appointed General Manager, Cronos Netherlands
“Our team has built a leading operation in the Wietexperiment, and with Cronos’ product innovation and global resources, we are well positioned to serve Dutch adult-use consumers and support the continued success of the program.”
Christopher Martens, Former CEO of CanAdelaar and newly appointed General Manager, Cronos Netherlands
“We believe the experiment provides an important opportunity to build a strong evidence base around the regulated production and supply of cannabis and to help inform the future development of Dutch cannabis policy.”
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA(1) in 2026 and 2027
Establishes Cronos’ European platform with #1 market share(2) in the largest adult-use cannabis market in Europe(3)
Get started
Create a free account to read the full story.